top of page
Are Traditional Preclinical Models Limiting Your Research? Leading Experts Explain Why Human-Based Models Matter
Learn how human-based models like iPSC-derived cardiomyocytes and 3D organoid systems improve translational outcomes in academic drug discovery.
Sep 15, 20259 min read
The Economic Case for Human-Based Preclinical Drug Testing: FDA’s NAMs Roadmap Explained
FDA NAMs Roadmap: Economic and Scientific Impact on Preclinical Drug Safety
Sep 9, 20256 min read
bottom of page